Hormone therapy increases risk of ulcerative colitis but not Crohn's disease

Gastroenterology

Volumn 143, Issue 5, 2012, Pages 1199-1206

  Khalili, Hamed ^a   Higuchi, Leslie M ^b   Ananthakrishnan, Ashwin N ^a   Manson, Joann E ^c   Feskanich, Diane ^c   Richter, James M ^a   Fuchs, Charles S ^c,d   Chan, Andrew T ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

IBD; Inflammatory Bowel Disease; Menopause; Predisposition

Indexed keywords

ESTROGEN; GESTAGEN;

AGE; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SMOKING; ULCERATIVE COLITIS;

EID: 84868103886     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.07.096     Document Type: Article

References (36)

1. C.A. Anderson, G. Boucher, C.W. Lees Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 Nat Genet 43 2011 246 252
2. A. Franke, D.P. McGovern, J.C. Barrett Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci Nat Genet 42 2010 1118 1125
3. C. Abraham, J.H. Cho Inflammatory bowel disease N Engl J Med 361 2009 2066 2078
4. C.G. Loftus, E.V. Loftus Jr, W.S. Harmsen Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000 Inflamm Bowel Dis 13 2007 254 261
5. E.V. Loftus Jr, P. Schoenfeld, W.J. Sandborn The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review Aliment Pharmacol Ther 16 2002 51 60
6. J.A. Cornish, E. Tan, C. Simillis The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis Am J Gastroenterol 103 2008 2394 2400
7. G.A. Colditz, M.J. Stampfer, W.C. Willett Reproducibility and validity of self-reported menopausal status in a prospective cohort study Am J Epidemiol 126 1987 319 325
8. D.A. Gonzalez, B.B. Diaz, C. Rodriguez Perez Mdel Sex hormones and autoimmunity Immunol Lett 133 2010 6 13
9. F. Grodstein, J.E. Manson, M.J. Stampfer Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy Arch Intern Med 168 2008 861 866
10. D.J. Hunter, J.E. Manson, G.A. Colditz Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women Contraception 56 1997 373 378
11. L.M. Troy, D.J. Hunter, J.E. Manson The validity of recalled weight among younger women Int J Obes Relat Metab Disord 19 1995 570 572
12. H. Khalili, E.S. Huang, A.N. Ananthakrishnan Geographical variation and incidence of inflammatory bowel disease among US women Gut 2012 Jan 11 [Epub ahead of print]
13. E.V. Loftus Jr, M.D. Silverstein, W.J. Sandborn Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival Gastroenterology 114 1998 1161 1168
14. E.V. Loftus Jr, M.D. Silverstein, W.J. Sandborn Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival Gut 46 2000 336 343
15. K. Fonager, H.T. Sorensen, S.N. Rasmussen Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system Scand J Gastroenterol 31 1996 154 159
16. B. Moum, M.H. Vatn, A. Ekbom Incidence of inflammatory bowel disease in southeastern Norway: evaluation of methods after 1 year of registration Southeastern Norway IBD Study Group of Gastroenterologists Digestion 56 1995 377 381
17. L.J. Herrinton, L. Liu, J.D. Lewis Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002 Am J Gastroenterol 103 2008 1998 2006
18. C.S. Baik, G.M. Strauss, F.E. Speizer Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses' Health Study Cancer Epidemiol Biomarkers Prev 19 2010 2525 2533
19. A.N. Ananthakrishnan, L.M. Higuchi, E.S. Huang Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study Ann Intern Med 156 2012 350 359
20. A.N. Ananthakrishnan, H. Khalili, L.M. Higuchi Higher predicted vitamin D status is associated with reduced risk of Crohn's disease Gastroenterology 142 2012 482 489
21. K.H. Costenbader, D. Feskanich, M.J. Stampfer Reproductive and menopausal factors and risk of systemic lupus erythematosus in women Arthritis Rheum 56 2007 1251 1262
22. F.B. Hu, W.C. Willett, T. Li Adiposity as compared with physical activity in predicting mortality among women N Engl J Med 351 2004 2694 2703
23. L.A. Garcia Rodriguez, A. Gonzalez-Perez, S. Johansson Risk factors for inflammatory bowel disease in the general population Aliment Pharmacol Ther 22 2005 309 315
24. C.W. Lees, J.C. Barrett, M. Parkes New IBD genetics: common pathways with other diseases Gut 60 2011 1739 1753
25. V. Braniste, A. Jouault, E. Gaultier Impact of oral bisphenol A at reference doses on intestinal barrier function and sex differences after perinatal exposure in rats Proc Natl Acad Sci U S A 107 2010 448 453
26. M. Looijer-van Langen, N. Hotte, L.A. Dieleman Estrogen receptor-beta signaling modulates epithelial barrier function Am J Physiol Gastrointest Liver Physiol 300 2011 G621 G626
27. I.J. Fuss, F. Heller, M. Boirivant Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis J Clin Invest 113 2004 1490 1497
28. I.J. Fuss, M. Neurath, M. Boirivant Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5 J Immunol 157 1996 1261 1270
29. F. Heller, P. Florian, C. Bojarski Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution Gastroenterology 129 2005 550 564
30. G. Monteleone, L. Biancone, R. Marasco Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells Gastroenterology 112 1997 1169 1178
31. M. Cutolo, S. Capellino, R.H. Straub Oestrogens in rheumatic diseases: friend or foe? Rheumatology (Oxford) 47 Suppl 3 2008 iii2 iii5
32. S.V. Kane, D. Reddy Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease Am J Gastroenterol 103 2008 1193 1196
33. L. Sarna, S.A. Bialous, H.J. Jun Smoking trends in the Nurses' Health Study (1976-2003) Nurs Res 57 2008 374 382
34. R.M. van Dam, T. Li, D. Spiegelman Combined impact of lifestyle factors on mortality: prospective cohort study in US women BMJ 337 2008 a1440
35. M. Walker Observation and inference: an introduction to the methods of epidemiology 1991 Epidemiology Resources Chestnut Hill, MA
36. J.E. Manson, J. Hsia, K.C. Johnson Estrogen plus progestin and the risk of coronary heart disease N Engl J Med 349 2003 523 534